ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tuna Oligopeptides Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-29S16480
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Tuna Oligopeptides Market Research Report 2024
BUY CHAPTERS

Global Tuna Oligopeptides Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-29S16480
Report
November 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thai Union Ingredients
Pingtairong Biotechnology
Natide (Yangjiang) Biotechnology
Taiai Peptide Biotechnology

Tuna Oligopeptides Market

The global Tuna Oligopeptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Health Products accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Tuna Oligopeptides leading manufacturers including Thai Union Ingredients, Pingtairong Biotechnology, Natide (Yangjiang) Biotechnology, Taiai Peptide Biotechnology, Lankun Marine Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Thai Union Ingredients leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Tuna Oligopeptides market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Tuna Oligopeptides Market Report

Report Metric Details
Report Name Tuna Oligopeptides Market
Segment by Type
  • Carnosine ＜4%
  • 4%-10% Carnosine
Segment by Application
  • Health Products
  • Food and Beverage
  • Cosmetics
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thai Union Ingredients, Pingtairong Biotechnology, Natide (Yangjiang) Biotechnology, Taiai Peptide Biotechnology, Lankun Marine Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Tuna Oligopeptides study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Tuna Oligopeptides Market report?

Ans: The main players in the Tuna Oligopeptides Market are Thai Union Ingredients, Pingtairong Biotechnology, Natide (Yangjiang) Biotechnology, Taiai Peptide Biotechnology, Lankun Marine Biotechnology

What are the Application segmentation covered in the Tuna Oligopeptides Market report?

Ans: The Applications covered in the Tuna Oligopeptides Market report are Health Products, Food and Beverage, Cosmetics, Other

What are the Type segmentation covered in the Tuna Oligopeptides Market report?

Ans: The Types covered in the Tuna Oligopeptides Market report are Carnosine ＜4%, 4%-10% Carnosine

1 Study Coverage
1.1 Introduction to Tuna Oligopeptides: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Tuna Oligopeptides Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Carnosine ＜4%
1.2.3 4%-10% Carnosine
1.3 Market Segmentation by Application
1.3.1 Global Tuna Oligopeptides Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Products
1.3.3 Food and Beverage
1.3.4 Cosmetics
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tuna Oligopeptides Revenue Estimates and Forecasts 2020-2031
2.2 Global Tuna Oligopeptides Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Tuna Oligopeptides Sales Estimates and Forecasts 2020-2031
2.4 Global Tuna Oligopeptides Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Tuna Oligopeptides Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Tuna Oligopeptides Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Tuna Oligopeptides Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Carnosine ＜4% Market Size by Manufacturers
4.5.2 4%-10% Carnosine Market Size by Manufacturers
4.6 Global Tuna Oligopeptides Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Tuna Oligopeptides Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Tuna Oligopeptides Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Tuna Oligopeptides Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Tuna Oligopeptides Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Tuna Oligopeptides Sales and Revenue by Type (2020-2031)
7.4 North America Tuna Oligopeptides Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Tuna Oligopeptides Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Tuna Oligopeptides Sales and Revenue by Type (2020-2031)
8.4 Europe Tuna Oligopeptides Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Tuna Oligopeptides Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Tuna Oligopeptides Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Tuna Oligopeptides Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Tuna Oligopeptides Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Tuna Oligopeptides Sales and Revenue by Type (2020-2031)
10.4 Central and South America Tuna Oligopeptides Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Tuna Oligopeptides Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Tuna Oligopeptides Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Tuna Oligopeptides Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Tuna Oligopeptides Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Thai Union Ingredients
12.1.1 Thai Union Ingredients Corporation Information
12.1.2 Thai Union Ingredients Business Overview
12.1.3 Thai Union Ingredients Tuna Oligopeptides Product Models, Descriptions and Specifications
12.1.4 Thai Union Ingredients Tuna Oligopeptides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Thai Union Ingredients Tuna Oligopeptides Sales by Product in 2024
12.1.6 Thai Union Ingredients Tuna Oligopeptides Sales by Application in 2024
12.1.7 Thai Union Ingredients Tuna Oligopeptides Sales by Geographic Area in 2024
12.1.8 Thai Union Ingredients Tuna Oligopeptides SWOT Analysis
12.1.9 Thai Union Ingredients Recent Developments
12.2 Pingtairong Biotechnology
12.2.1 Pingtairong Biotechnology Corporation Information
12.2.2 Pingtairong Biotechnology Business Overview
12.2.3 Pingtairong Biotechnology Tuna Oligopeptides Product Models, Descriptions and Specifications
12.2.4 Pingtairong Biotechnology Tuna Oligopeptides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Pingtairong Biotechnology Tuna Oligopeptides Sales by Product in 2024
12.2.6 Pingtairong Biotechnology Tuna Oligopeptides Sales by Application in 2024
12.2.7 Pingtairong Biotechnology Tuna Oligopeptides Sales by Geographic Area in 2024
12.2.8 Pingtairong Biotechnology Tuna Oligopeptides SWOT Analysis
12.2.9 Pingtairong Biotechnology Recent Developments
12.3 Natide (Yangjiang) Biotechnology
12.3.1 Natide (Yangjiang) Biotechnology Corporation Information
12.3.2 Natide (Yangjiang) Biotechnology Business Overview
12.3.3 Natide (Yangjiang) Biotechnology Tuna Oligopeptides Product Models, Descriptions and Specifications
12.3.4 Natide (Yangjiang) Biotechnology Tuna Oligopeptides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Natide (Yangjiang) Biotechnology Tuna Oligopeptides Sales by Product in 2024
12.3.6 Natide (Yangjiang) Biotechnology Tuna Oligopeptides Sales by Application in 2024
12.3.7 Natide (Yangjiang) Biotechnology Tuna Oligopeptides Sales by Geographic Area in 2024
12.3.8 Natide (Yangjiang) Biotechnology Tuna Oligopeptides SWOT Analysis
12.3.9 Natide (Yangjiang) Biotechnology Recent Developments
12.4 Taiai Peptide Biotechnology
12.4.1 Taiai Peptide Biotechnology Corporation Information
12.4.2 Taiai Peptide Biotechnology Business Overview
12.4.3 Taiai Peptide Biotechnology Tuna Oligopeptides Product Models, Descriptions and Specifications
12.4.4 Taiai Peptide Biotechnology Tuna Oligopeptides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Taiai Peptide Biotechnology Tuna Oligopeptides Sales by Product in 2024
12.4.6 Taiai Peptide Biotechnology Tuna Oligopeptides Sales by Application in 2024
12.4.7 Taiai Peptide Biotechnology Tuna Oligopeptides Sales by Geographic Area in 2024
12.4.8 Taiai Peptide Biotechnology Tuna Oligopeptides SWOT Analysis
12.4.9 Taiai Peptide Biotechnology Recent Developments
12.5 Lankun Marine Biotechnology
12.5.1 Lankun Marine Biotechnology Corporation Information
12.5.2 Lankun Marine Biotechnology Business Overview
12.5.3 Lankun Marine Biotechnology Tuna Oligopeptides Product Models, Descriptions and Specifications
12.5.4 Lankun Marine Biotechnology Tuna Oligopeptides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Lankun Marine Biotechnology Tuna Oligopeptides Sales by Product in 2024
12.5.6 Lankun Marine Biotechnology Tuna Oligopeptides Sales by Application in 2024
12.5.7 Lankun Marine Biotechnology Tuna Oligopeptides Sales by Geographic Area in 2024
12.5.8 Lankun Marine Biotechnology Tuna Oligopeptides SWOT Analysis
12.5.9 Lankun Marine Biotechnology Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Tuna Oligopeptides Industry Chain
13.2 Tuna Oligopeptides Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Tuna Oligopeptides Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Tuna Oligopeptides Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Tuna Oligopeptides Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Tuna Oligopeptides Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Thai Union Ingredients
Pingtairong Biotechnology
Natide (Yangjiang) Biotechnology
Taiai Peptide Biotechnology
List of Tables
 Table 1. Global Tuna Oligopeptides Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Tuna Oligopeptides Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Tuna Oligopeptides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Tuna Oligopeptides Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Tuna Oligopeptides Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Tuna Oligopeptides Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Tuna Oligopeptides Sales by Region (2020-2025) & (Tons)
 Table 8. Global Tuna Oligopeptides Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Tuna Oligopeptides Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Tuna Oligopeptides Production by Region (2020-2025) & (Tons)
 Table 12. Global Tuna Oligopeptides Production by Region (2026-2031) & (Tons)
 Table 13. Global Tuna Oligopeptides Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Tuna Oligopeptides Sales Share by Manufacturers (2020-2025)
 Table 15. Global Tuna Oligopeptides Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Tuna Oligopeptides Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Tuna Oligopeptides by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuna Oligopeptides as of 2024)
 Table 19. Global Tuna Oligopeptides Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Tuna Oligopeptides Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Tuna Oligopeptides Manufacturing Base and Headquarters
 Table 22. Global Tuna Oligopeptides Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Tuna Oligopeptides Sales by Type (2020-2025) & (Tons)
 Table 26. Global Tuna Oligopeptides Sales by Type (2026-2031) & (Tons)
 Table 27. Global Tuna Oligopeptides Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Tuna Oligopeptides Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Tuna Oligopeptides ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Tuna Oligopeptides Sales by Application (2020-2025) & (Tons)
 Table 32. Global Tuna Oligopeptides Sales by Application (2026-2031) & (Tons)
 Table 33. Tuna Oligopeptides High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Tuna Oligopeptides Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Tuna Oligopeptides Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Tuna Oligopeptides ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Tuna Oligopeptides Growth Accelerators and Market Barriers
 Table 40. North America Tuna Oligopeptides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Tuna Oligopeptides Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Tuna Oligopeptides Growth Accelerators and Market Barriers
 Table 43. Europe Tuna Oligopeptides Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Tuna Oligopeptides Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Tuna Oligopeptides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Tuna Oligopeptides Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Tuna Oligopeptides Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Tuna Oligopeptides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Tuna Oligopeptides Investment Opportunities and Key Challenges
 Table 50. Central and South America Tuna Oligopeptides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Tuna Oligopeptides Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Tuna Oligopeptides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Thai Union Ingredients Corporation Information
 Table 54. Thai Union Ingredients Description and Major Businesses
 Table 55. Thai Union Ingredients Product Models, Descriptions and Specifications
 Table 56. Thai Union Ingredients Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Thai Union Ingredients Sales Value Proportion by Product in 2024
 Table 58. Thai Union Ingredients Sales Value Proportion by Application in 2024
 Table 59. Thai Union Ingredients Sales Value Proportion by Geographic Area in 2024
 Table 60. Thai Union Ingredients Tuna Oligopeptides SWOT Analysis
 Table 61. Thai Union Ingredients Recent Developments
 Table 62. Pingtairong Biotechnology Corporation Information
 Table 63. Pingtairong Biotechnology Description and Major Businesses
 Table 64. Pingtairong Biotechnology Product Models, Descriptions and Specifications
 Table 65. Pingtairong Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Pingtairong Biotechnology Sales Value Proportion by Product in 2024
 Table 67. Pingtairong Biotechnology Sales Value Proportion by Application in 2024
 Table 68. Pingtairong Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 69. Pingtairong Biotechnology Tuna Oligopeptides SWOT Analysis
 Table 70. Pingtairong Biotechnology Recent Developments
 Table 71. Natide (Yangjiang) Biotechnology Corporation Information
 Table 72. Natide (Yangjiang) Biotechnology Description and Major Businesses
 Table 73. Natide (Yangjiang) Biotechnology Product Models, Descriptions and Specifications
 Table 74. Natide (Yangjiang) Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Natide (Yangjiang) Biotechnology Sales Value Proportion by Product in 2024
 Table 76. Natide (Yangjiang) Biotechnology Sales Value Proportion by Application in 2024
 Table 77. Natide (Yangjiang) Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 78. Natide (Yangjiang) Biotechnology Tuna Oligopeptides SWOT Analysis
 Table 79. Natide (Yangjiang) Biotechnology Recent Developments
 Table 80. Taiai Peptide Biotechnology Corporation Information
 Table 81. Taiai Peptide Biotechnology Description and Major Businesses
 Table 82. Taiai Peptide Biotechnology Product Models, Descriptions and Specifications
 Table 83. Taiai Peptide Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Taiai Peptide Biotechnology Sales Value Proportion by Product in 2024
 Table 85. Taiai Peptide Biotechnology Sales Value Proportion by Application in 2024
 Table 86. Taiai Peptide Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 87. Taiai Peptide Biotechnology Tuna Oligopeptides SWOT Analysis
 Table 88. Taiai Peptide Biotechnology Recent Developments
 Table 89. Lankun Marine Biotechnology Corporation Information
 Table 90. Lankun Marine Biotechnology Description and Major Businesses
 Table 91. Lankun Marine Biotechnology Product Models, Descriptions and Specifications
 Table 92. Lankun Marine Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Lankun Marine Biotechnology Sales Value Proportion by Product in 2024
 Table 94. Lankun Marine Biotechnology Sales Value Proportion by Application in 2024
 Table 95. Lankun Marine Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 96. Lankun Marine Biotechnology Tuna Oligopeptides SWOT Analysis
 Table 97. Lankun Marine Biotechnology Recent Developments
 Table 98. Key Raw Materials Distribution
 Table 99. Raw Materials Key Suppliers
 Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 101. Milestones in Production Technology Evolution
 Table 102. Distributors List
 Table 103. Market Trends and Market Evolution
 Table 104. Market Drivers and Opportunities
 Table 105. Market Challenges, Risks, and Restraints
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. Tuna Oligopeptides Product Picture
 Figure 2. Global Tuna Oligopeptides Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Carnosine ＜4% Product Picture
 Figure 4. 4%-10% Carnosine Product Picture
 Figure 5. Global Tuna Oligopeptides Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Health Products
 Figure 7. Food and Beverage
 Figure 8. Cosmetics
 Figure 9. Other
 Figure 10. Tuna Oligopeptides Report Years Considered
 Figure 11. Global Tuna Oligopeptides Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Tuna Oligopeptides Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Tuna Oligopeptides Revenue Market Share by Region (2020-2031)
 Figure 15. Global Tuna Oligopeptides Sales (2020-2031) & (Tons)
 Figure 16. Global Tuna Oligopeptides Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global Tuna Oligopeptides Sales Market Share by Region (2020-2031)
 Figure 18. Global Tuna Oligopeptides Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global Tuna Oligopeptides Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global Tuna Oligopeptides Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Tuna Oligopeptides Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. Tuna Oligopeptides Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. Tuna Oligopeptides Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. Tuna Oligopeptides Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers Tuna Oligopeptides Sales Volume Market Share in 2024
 Figure 27. Global Tuna Oligopeptides Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. Carnosine ＜4% Revenue Market Share by Manufacturer in 2024
 Figure 30. 4%-10% Carnosine Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global Tuna Oligopeptides Sales Market Share by Type (2020-2031)
 Figure 34. Global Tuna Oligopeptides Revenue Market Share by Type (2020-2031)
 Figure 35. Global Tuna Oligopeptides Sales Market Share by Application (2020-2031)
 Figure 36. Global Tuna Oligopeptides Revenue Market Share by Application (2020-2031)
 Figure 37. North America Tuna Oligopeptides Sales YoY (2020-2031) & (Tons)
 Figure 38. North America Tuna Oligopeptides Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers Tuna Oligopeptides Sales Revenue (US$ Million) in 2024
 Figure 40. North America Tuna Oligopeptides Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America Tuna Oligopeptides Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America Tuna Oligopeptides Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America Tuna Oligopeptides Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe Tuna Oligopeptides Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe Tuna Oligopeptides Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers Tuna Oligopeptides Sales Revenue (US$ Million) in 2024
 Figure 50. Europe Tuna Oligopeptides Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe Tuna Oligopeptides Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe Tuna Oligopeptides Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe Tuna Oligopeptides Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 55. France Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific Tuna Oligopeptides Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific Tuna Oligopeptides Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers Tuna Oligopeptides Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific Tuna Oligopeptides Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific Tuna Oligopeptides Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific Tuna Oligopeptides Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific Tuna Oligopeptides Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 70. India Tuna Oligopeptides Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America Tuna Oligopeptides Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America Tuna Oligopeptides Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers Tuna Oligopeptides Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America Tuna Oligopeptides Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America Tuna Oligopeptides Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America Tuna Oligopeptides Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America Tuna Oligopeptides Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil Tuna Oligopeptides Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina Tuna Oligopeptides Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa Tuna Oligopeptides Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa Tuna Oligopeptides Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers Tuna Oligopeptides Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa Tuna Oligopeptides Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America Tuna Oligopeptides Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa Tuna Oligopeptides Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa Tuna Oligopeptides Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries Tuna Oligopeptides Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey Tuna Oligopeptides Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt Tuna Oligopeptides Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa Tuna Oligopeptides Revenue (2020-2025) & (US$ Million)
 Figure 91. Tuna Oligopeptides Industry Chain Mapping
 Figure 92. Regional Tuna Oligopeptides Manufacturing Base Distribution (%)
 Figure 93. Tuna Oligopeptides Production Process
 Figure 94. Regional Tuna Oligopeptides Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Tunas Market Research Report 2025
Global Tuna Seafood Market Research Report 2025
Global Corn Oligopeptides Market Research Report 2024
Packaged Tuna Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuna Oil Market Research Report 2025
Global Frozen Tuna Market Research Report 2025
Global Tuna Fish Oil Market Research Report 2025
Global Tuna Fishing Vessels Market Research Report 2024
Global Farmed Bluefin Tuna Market Research Report 2025
Global Wheat Oligopeptides Market Research Report 2024
Global Peptide Analysis Market Research Report 2025
Global Freshwater Fish Protein Peptides Market Research Report 2025
Global Peptide Antibiotics Market Research Report 2025
Global Fish Products Market Research Report 2024
Global Tuna Canning Machine Market Research Report 2025
Global GMP Grade Peptide Market Research Report 2024
Global Ovalbumin Peptide Market Research Report 2024
Global Marine Bioactive Peptides Market Research Report 2024
Global Canned and Pouched Tuna Market Research Report 2024
Global Fish Peptones Market Research Report 2024

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions